After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of EyePoint Pharmaceuticals Inc is $712.89M. A total of 0.9 million shares were traded on the day, compared to an average of 807.62K shares.
In the most recent transaction, Zaderej Karen L. bought 5,000 shares of EYPT for 5.99 per share on May 19 ’25. After the transaction, the Director now owns 36,500 company shares. In a previous transaction on May 16 ’25, Zaderej Karen L. bought 5,000 shares at 5.81 per share. EYPT shares that Director owns now total 31,500.
Among the insiders who bought shares, Zaderej Karen L. acquired of 5,000 shares on May 15 ’25 at a per-share price of $5.47. This resulted in the Director holding 26,500 shares of EYPT after the transaction. In another insider transaction, Zaderej Karen L. bought 5,000 shares at $5.42 per share on May 14 ’25. Company shares held by the Director now total 21,500.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, EYPT has a high of $13.98 and a low of $3.91.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. EYPT’s latest balance sheet shows that the firm has $211.56M in Cash & Short Term Investments as of fiscal 2021. There were $39.20M in debt and $23.66M in liabilities at the time. Its Book Value Per Share was $4.34, while its Total Shareholder’s Equity was $184.38M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EYPT is Buy with a score of 4.92.
